INIS
assessments
6%
bacillus
5%
bladder
57%
blood
5%
cancer
100%
carcinomas
10%
chemotherapy
8%
comparative evaluations
12%
cost
18%
data
14%
diseases
13%
epidemiology
5%
hazards
9%
hospitals
8%
interventions
5%
kidneys
9%
length
5%
levels
5%
lymph nodes
12%
management
13%
margins
6%
men
16%
metastases
8%
mortality
9%
muscles
24%
nephrectomy
5%
patients
85%
populations
13%
prostate
37%
radiations
5%
radiotherapy
7%
reviews
18%
risks
35%
robots
16%
surgery
30%
surveillance
10%
testes
7%
therapy
23%
tumors
14%
usa
5%
values
5%
volume
5%
Medicine and Dentistry
Analysis
9%
Bladder Cancer
25%
Clinical Stage
5%
Cystectomy
16%
Development
6%
Diagnosis
7%
Disease
5%
Hazard Ratio
6%
Health Care Cost
13%
Hospital
7%
Inpatient
10%
Malignant Neoplasm
13%
Man
13%
Mortality
6%
Muscle Invasive Bladder Cancer
12%
Non Muscle Invasive Bladder Cancer
6%
Odds Ratio
7%
Patient
60%
Prostate Cancer
23%
Prostatectomy
16%
Radiation Therapy
5%
Retroperitoneal Lymph Node Dissection
9%
Robot-Assisted Prostatectomy
7%
Surgery
9%
Surgical Margin
5%
Survival
8%
Systematic Review
6%
Therapeutic Procedure
27%
Urologist
5%
Keyphrases
Bladder Cancer
7%
Confidence Interval
5%